Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The inheritance of only one mutated beta-globin allele (beta+ or beta0).
Biomarker and diagnostic research for thalassemia minor has been reported in the published literature.
13 clinical trials registered, 6 recruiting. Interventions under study include drug therapy, biologic therapy, other interventions, and procedural interventions. Pipeline includes 4 PHASE3, 3 PHASE2, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06213402](https://clinicaltrials.gov/study/NCT06213402) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:53 PM UTC
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) |
— |
Hospital Universitari Vall d'Hebron Research Institute |
RECRUITING |
[NCT04872179](https://clinicaltrials.gov/study/NCT04872179) | International Registry of Patients With Alpha Thalassemia | — | University of California, San Francisco | RECRUITING |
[NCT05736419](https://clinicaltrials.gov/study/NCT05736419) | A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) | PHASE2 | Memorial Sloan Kettering Cancer Center | RECRUITING |
[NCT06073860](https://clinicaltrials.gov/study/NCT06073860) | A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia | — | Bristol-Myers Squibb | RECRUITING |
[NCT05477563](https://clinicaltrials.gov/study/NCT05477563) | Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease | PHASE3 | Vertex Pharmaceuticals Incorporated | RECRUITING |
137 publications have been identified in PubMed for thalassemia minor. Research spans Case Report / Case Series (35%), Epidemiology / Natural History (24%), and Diagnostic / Biomarker (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 48 | 35% |
Disease patterns and progression | 33 | 24% |
Testing and diagnosis research | 28 | 20% |
Laboratory research | 11 | 8% |
Research summaries | 9 | 7% |
Clinical study results | 5 | 4% |
Other research | 2 | 1% |
New treatment approaches | 1 | 1% |
Preechathaveekid S (2026). [PMID: 42272137](https://pubmed.ncbi.nlm.nih.gov/42272137/). *Hemoglobin*. [Case Report / Case Series]
Yağmur I (2026). [PMID: 41633612](https://pubmed.ncbi.nlm.nih.gov/41633612/). *Hemoglobin*. [Diagnostic / Biomarker]
Yapa CN (2026). [PMID: 41639910](https://pubmed.ncbi.nlm.nih.gov/41639910/). *BMC Res Notes*. [Diagnostic / Biomarker]
Mohama D (2026). [PMID: 41342807](https://pubmed.ncbi.nlm.nih.gov/41342807/). *JACC. Case reports*. [Case Report / Case Series]
Bonifanti L (2026). [PMID: 41755985](https://pubmed.ncbi.nlm.nih.gov/41755985/). *Cureus*. [Case Report / Case Series]
Hexner-Erlichman Z (2026). [PMID: 41977390](https://pubmed.ncbi.nlm.nih.gov/41977390/). *Int J Mol Sci*. [Epidemiology / Natural History]
Uze Okay Z (2026). [PMID: 41790707](https://pubmed.ncbi.nlm.nih.gov/41790707/). *Medicine*. [Epidemiology / Natural History]
Busti F (2026). [PMID: 40931872](https://pubmed.ncbi.nlm.nih.gov/40931872/). *Haematologica*. [Case Report / Case Series]
Kyriakopoulos AM (2026). [PMID: 41606631](https://pubmed.ncbi.nlm.nih.gov/41606631/). *Journal of medical case reports*. [Review / Meta-Analysis]
Gerede A (2026). [PMID: 42201017](https://pubmed.ncbi.nlm.nih.gov/42201017/). *Med Sci (Basel)*. [Review / Meta-Analysis]